The COA Virtual Annual Meeting (April 23-24, 2020) had an educational agenda planned to benefit the nationwide workforce of community oncology professionals and allied industries. It was delivered through a cutting-edge webcast system with interactive features.
Journal of Clinical Pathways provided coverage of the most relevant and important sessions of the meeting.
Jeffrey F Patton, MD, chief executive officer, Tennessee Oncology, reflected on the important happenings of the COA Annual Meeting and the outlook of community oncology at the present as well as the immediate future.
A panel moderated by Fred Schnell, MD, explored the business, manufacturer, and employer views regarding care costs and benefit design in the employer space.
A diverse panel considered the utility of a comprehensive genomic profile, issues of reimbursement for genomic tests, and the role of pathways in mitigating these issues.
Debra Patt, MD, PhD, MBA, FASCO, spoke to how applied informatics in cancer care can have a significant impact in telehealth, big data, and decision support initiatives.
Howard “Skip” Burris, III, MD, FACP, FASCO, discussed the infrastructure and support needed for a successful community oncology clinical research program.
Presenters Bo Gamble, Lalan Wilfong, MD, and Kashyap Patel, MD, discussed COA’s thoughts, present and future, regarding the OCM, OCM 2.0, and the CMMI Oncology Care First model.
Panelists weighed the current challenges in community oncology, including meeting the demands of a technology-based world and performance in value-based models during the COVID-19 pandemic.
On the eve of the COA Virtual Annual Meeting, Fred Schnell, MD, FACP, chief medical officer of COA, spoke to the exciting sessions at the meeting, why the pathways audience should be tuned in, and the growing excitement surrounding the 2020 Oncology Clinical Pathways Congress.